IGAM
GILD icon

iA Global Asset Management’s Gilead Sciences GILD Stock Holding History

iA Global Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.8M Sell
148,928
-74,835
-33% -$9.86M 0.22% 91
2026
Q1 		$31.2M Sell
223,763
-11,622
-5% -$1.63M 0.44% 53
2025
Q4 		$28.9M Buy
235,385
+13,495
+6% +$1.64M 0.37% 60
2025
Q3 		$24.6M Buy
221,890
+23,046
+12% +$2.62M 0.34% 61
2025
Q2 		$22M Buy
198,844
+6,297
+3% +$670K 0.33% 62
2025
Q1 		$21.6M Sell
192,547
-7,335
-4% -$757K 0.37% 55
2024
Q4 		$18.5M Buy
199,882
+24,815
+14% +$2.23M 0.32% 59
2024
Q3 		$14.7M Buy
175,067
+22,228
+15% +$1.7M 0.26% 76
2024
Q2 		$10.5M Sell
152,839
-27,802
-15% -$1.86M 0.2% 88
2024
Q1 		$13.2M Buy
180,641
+8,350
+5% +$642K 0.27% 77
2023
Q4 		$14M Buy
172,291
+17,905
+12% +$1.39M 0.32% 64
2023
Q3 		$11.6M Buy
154,386
+37,763
+32% +$2.9M 0.31% 79
2023
Q2 		$8.99M Buy
+116,623
New +$9.3M 0.24% 81

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

iA Global Asset Management's GILD Position: Q2 2026 in Review

iA Global Asset Management reduced its Gilead Sciences (GILD) stake by 33% in Q2 2026, selling an estimated $9.86M and leaving 148,928 shares worth $18.8M. The position accounts for 0.22% of the portfolio, ranked #91.

iA Global Asset Management first reported a position in GILD in Q2 2023 and has held it in 13 quarters since. The position peaked at $31.2M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • iA Global Asset Management held 148,928 shares of Gilead Sciences worth $18.8M as of Q2 2026.
  • iA Global Asset Management sold 74,835 Gilead Sciences shares in Q2 2026, an estimated $9.86M.
  • Gilead Sciences made up 0.22% of iA Global Asset Management's portfolio in Q2 2026, its #91 holding.
  • iA Global Asset Management first reported a position in Gilead Sciences in Q2 2023 and has held it in 13 quarters since.
  • iA Global Asset Management's Gilead Sciences position peaked at $31.2M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.